AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12139821
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of nitroglycerin patches
Trial: 10565799
Drug: mirtazapine (15-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mirtazapine (15-60 mg/day)
Trial: 10565799
Drug: citalopram (20-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: citalopram (20-60 mg/day)
Trial: 7881961
Drug: High-lipid intravenous
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-lipid intravenous nutrition (75% non-protein calories supplied as lipid)
Trial: 7881961
Drug: Isocaloric isonitrogenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isocaloric isonitrogenous glucose intravenous nutrition (100% non-protein calories supplied as glucose)
Trial: 2404434
Drug: Diphenhydramine 50
RxNorm normalized name: diphenhydrAMINE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 50 mg IM
Trial: 2404434
Drug: Cimetidine 300
RxNorm normalized name: cimetidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 300 mg IM
Trial: 6776755
Drug: Levo-norgestrel (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levo-norgestrel (250 microgram daily) and testosterone oenanthate (200 mg monthly)
Trial: 6776755
Drug: Levo-norgestrel (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levo-norgestrel (500 microgram daily) and testosterone oenanthate (200 mg monthly)
Trial: 6776755
Drug: Levo-norgestrel (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levo-norgestrel (250 or 500 microgram daily) and testosterone oenanthate (200 mg monthly)
Trial: 6776755
Drug: Recovery phase
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recovery phase after treatment
Trial: 31532138
Drug: Otopoint pellet-pressing
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otopoint pellet-pressing plus medication (Flunarizine 10 mg twice a day)
Trial: 31532138
Drug: Medication (Flunarizine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Flunarizine 10 mg twice a day)
Trial: 26555069
Drug: cART plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cART plus integrase inhibitor and CCR5 antagonist (cART+; raltegravir and maraviroc)
Trial: 21308888
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) for social phobia
Trial: 19438993
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (30 mg daily for 4 days)
Trial: 17347181
Drug: Tetracaine 15
RxNorm normalized name: Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oromucosal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracaine 15 mg in 3 ml of glucose 5% (hyperbaric)
Trial: 17347181
Drug: Tetracaine 15
RxNorm normalized name: Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oromucosal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracaine 15 mg in 3 ml of CSF (isobaric)
Trial: 16797292
Drug: Strict sodium
RxNorm normalized name: Euphrasia stricta extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strict sodium diet (80 to 100 mmol sodium daily)
Trial: 15012700
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no sertraline)
Trial: 10802128
Drug: Citalopram infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram infusion (40 mg per day)
Trial: 10802128
Drug: Citalopram tablet
RxNorm normalized name: Citalopram Tablets
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram tablet (40 mg per day)
Trial: 1839714
Drug: Inhaled anesthetic
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled anesthetic
Trial: 31158254
Drug: Gardasil-9 vaccine
RxNorm normalized name: Gardasil 9
DrugBank: Human papillomavirus type 58 L1 capsid protein antigen (DB10314)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gardasil-9 vaccine genotypes
Trial: 15511336
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (50-150 mg/day for 5 days)
Trial: 15511336
Drug: Low-dose recombinant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose recombinant FSH (daily starting dose 75 IU for up to three consecutive cycles)
Trial: 15511336
Drug: Low-dose recombinant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose recombinant FSH
Trial: 8174308
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate super‐imposed on cyclical hormonal replacement therapy (HRT)
Trial: 3207544
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg by mouth 8‐14 h and 50 mg i.m. 90 min before surgery
Trial: 3207544
Drug: Ranitidine 50
RxNorm normalized name: ranitidine 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 50 mg i.m. 6‐hourly with a single preinduction dose of sodium citrate 0.3 mol litre‐1 (15 or 30 ml)
Trial: 3207544
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate 0.3 mol litre‐1 (15 or 30 ml)
Trial: 28679524
Drug: rosuvastatin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin treatment for 12 months
Trial: 25788006
Drug: Monosodium glutamate/isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monosodium glutamate/isotonic saline (MSG/IS) injection in TMJ
Trial: 25788006
Drug: Monosodium glutamate/isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monosodium glutamate/isotonic saline (MSG/IS) injection in masseter
Trial: 25788006
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline (IS) injection in masseter
Trial: 25788006
Drug: Monosodium glutamate/isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monosodium glutamate/isotonic saline (MSG/IS) injection in masseter and TMJ
Trial: 25788006
Drug: Painful masseter
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Painful masseter injection
Trial: 25788006
Drug: Painful TMJ
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Painful TMJ injection
Trial: 17903498
Drug: Continuous thoracic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous thoracic epidural analgesia with 0.2% ropivacaine containing 2 microg/mL fentanyl
Trial: 17903498
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia with morphine
Trial: 12357520
Drug: Intra-aortic balloon
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-aortic balloon (IAB) counterpulsation with inflation volume of 32 cc
Trial: 12357520
Drug: Intra-aortic balloon
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-aortic balloon (IAB) counterpulsation with inflation volume of 40 cc
Trial: 734578
Drug: Segmental epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Segmental epidural block with lower dosages of bupivacaine; specific dosage not mentioned; technique involved patients kneeling on all fours.
Trial: 30676045
Drug: Brief Warrior
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Warrior Renew treatment (8 sessions)
Trial: 25638038
Drug: Tailored, personalized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored, personalized site (treatment)
Trial: 19357698
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg and HCTZ 25 mg
Trial: 19357698
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg and HCTZ 25 mg
Trial: 11340684
Drug: Inhaled recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled recombinant human DNase (rhDNase)
Trial: 30154254
Drug: Stent retriever
RxNorm normalized name: LidoPro Pain Relieving Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stent retriever (SR) treatment with SVS present
Trial: 30154254
Drug: Stent retriever
RxNorm normalized name: LidoPro Pain Relieving Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stent retriever (SR) treatment without SVS
Trial: 23925452
Drug: Modafinil (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (up to 400 mg/day)
Trial: 21830049
Drug: Titration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration of sevoflurane based on SEDLine™ data
Trial: 17910221
Drug: Control (without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (without application of a desensitizing agent)
Trial: 17910221
Drug: Fluor Protector
RxNorm normalized name: Fluor a Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluor Protector (desensitizing treatment)
Trial: 17910221
Drug: VivaSens (desensitizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VivaSens (desensitizing treatment)
Trial: 17910221
Drug: Isodan (desensitizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isodan (desensitizing treatment)
Trial: 17910221
Drug: Futura Bond
RxNorm normalized name: SKIN BOND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Futura Bond NR (desensitizing treatment)
Trial: 17910221
Drug: Nd:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nd:YAG laser (desensitizing treatment)
Trial: 15133865
Drug: Bifid triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifid triple viable capsule (BIFICO) (1.26 g/d)
Trial: 8333941
Drug: 1% fusidic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% fusidic acid viscous eye drops, self-administered four times daily for seven days before surgery
Trial: 8333941
Drug: Placebo (inert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inert ophthalmic drops)
Trial: 3080285
Drug: misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: misoprostol (200 micrograms four times daily) with tolmetin (2000 mg/day, in four divided doses)
Trial: 3080285
Drug: placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo with tolmetin (2000 mg/day, in four divided doses)
Trial: 24206547
Drug: Intermittent Boluses
RxNorm normalized name: phenylbutazone
DrugBank: Phenylbutazone (DB00812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent Boluses (IB) - 20 mg propofol boluses on demand
Trial: 24206547
Drug: Pump Continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pump Continuous Infusion (PCI) - 3 mg/kg/h plus 20 mg boluses on demand
Trial: 19593179
Drug: Chamomile extract
RxNorm normalized name: Chamomile Extract
DrugBank: Chamomile (DB14357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile extract therapy
Trial: 17229901
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein (40 g soy protein, 118 mg isoflavones)
Trial: 12774015
Drug: Amantadine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine group (amantadine sulphate 100 mg twice daily orally)
Trial: 18656314
Drug: Daily smokers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily smokers
Trial: 9216458
Drug: Weekly alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly alcohol consumption
Trial: 8267669
Drug: Oxerutins (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxerutins (900 mg/day for 12 weeks)
Trial: 8267669
Drug: Troxerutin (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troxerutin (900 mg/day for 12 weeks)
Trial: 29569219
Drug: Cabergoline (D2-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (D2-receptor agonist)
Trial: 23840645
Drug: Wake therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wake therapy (sleep deprivation) combined with light therapy and sleep time stabilisation
Trial: 2554630
Drug: Desferrioxamine B
RxNorm normalized name: Deferrioxamine B
DrugBank: Deferoxamine (DB00746)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desferrioxamine B 500 mg intravenously followed by packed red cell transfusion
Trial: 782774
Drug: Butorphanol 1
RxNorm normalized name: butorphanol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 1 mg/70 kg
Trial: 782774
Drug: Butorphanol 2
RxNorm normalized name: butorphanol 2 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 2 mg/70 kg
Trial: 782774
Drug: Butorphanol 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 4 mg/70 kg
Trial: 782774
Drug: Meperidine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 40 mg/70 kg
Trial: 782774
Drug: Meperidine 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 80 mg/70 kg
Trial: 30415628
Drug: Icosapent ethyl
RxNorm normalized name: Icosapent Ethyl
DrugBank: Icosapent ethyl (DB08887)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Icosapent ethyl (2 g twice daily, total daily dose 4 g)
Trial: 29925712
Drug: 1% malic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% malic acid spray
Trial: 26572686
Drug: Faldaprevir 240
RxNorm normalized name: Faldaprévir
DrugBank: Faldaprevir (DB11808)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Faldaprevir 240 mg once daily plus PegIFN/RBV for 24 weeks
Trial: 22229837
Drug: Transdermal sumatriptan
RxNorm normalized name: sumatriptan Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal sumatriptan
Trial: 14722645
Drug: 0.28 g
RxNorm normalized name: DIBUCAINE 0.28 g in 28 g TOPICAL OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.28 g of glutamine per kg bodyweight per day intravenously for five days
Trial: 14722645
Drug: 0.57 g
RxNorm normalized name: OATMEAL 0.57 g in 0.57 g TOPICAL SALVE [Superbalm]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.57 g of glutamine per kg bodyweight per day intravenously for five days
Trial: 14722645
Drug: 0.86 g
RxNorm normalized name: MENTHOL, UNSPECIFIED FORM 0.86 g in 1 g ORAL LOZENGE [Menthol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.86 g of glutamine per kg bodyweight per day intravenously for five days
Trial: 14722645
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g of glutamine per kg bodyweight per day intravenously for five days (control)
Trial: 12201937
Drug: ESWL with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESWL with diuresis (i.v. infusion of 500 ml normal saline containing 40 mg furosemide)
Trial: 9653697
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of azithromycin
Trial: 9653697
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of azithromycin (for patients)
Trial: 8581842
Drug: Local nasal
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local nasal immunotherapy (LNIT) with allergen in powder form
Trial: 2523787
Drug: Metformin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (0.5 g x 3 daily)
Trial: 1261583
Drug: Verapamil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (0.1 mg/kg i.v.)
Trial: 795700
Drug: Dipyridamol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamol (20 mg i.v.)
Trial: 795700
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 ml saline i.v.)
Trial: 24113028
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral 100 mg enteric-coated aspirin
Trial: 21437676
Drug: Operational multidisciplinary
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Operational multidisciplinary antibiotic team
Trial: 11541691
Drug: Transdermal scopolamine
RxNorm normalized name: Transderm Scop
DrugBank: Scopolamine (DB00747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal scopolamine (TAS)
Trial: 11541691
Drug: Intramuscularly administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscularly administered promethazine
Trial: 31284424
Drug: Partly fermented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partly fermented infant formula with 30% fermented formula and 0.8 g/100 mL scGOS/lcFOS
Trial: 23079125
Drug: MTX 7.5‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTX 7.5‐20 mg/week + cyclosporine (CYA) 2.5‐4 mg/kg (combination)
Trial: 23079125
Drug: MTX +
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX + placebo-CYA (monotherapy)
Trial: 20659915
Drug: Dexamethasone 0.5
RxNorm normalized name: dexamethasone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.5 mg kg(‐1) (maximum 10 mg)
Trial: 16251562
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of 0.2% hypobaric tetracaine
Trial: 16251562
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg of 0.2% hypobaric tetracaine
Trial: 16251562
Drug: 14 mg
RxNorm normalized name: iodine 0.14 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 mg of 0.2% hypobaric tetracaine
Trial: 12087923
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of nifedipine in the test preparation 'XL' (Nifecard)
Trial: 12087923
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of nifedipine in the reference formulation 'LA'
Trial: 1416009
Drug: Sprotte 24
RxNorm normalized name: BRUSSELS SPROUT
DrugBank: Brussels sprout (DB10642)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sprotte 24 G needle (n = 28)
Trial: 1416009
Drug: Vygon 29
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vygon 29 G needle (n = 28)
Trial: 3890228
Drug: Gentamicin (280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (280 mg, single dose, intramuscularly)
Trial: 3890228
Drug: Kanamycin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kanamycin (2 g, single dose, intramuscularly)
Trial: 26978136
Drug: Subfascial administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subfascial administration of 3 g of tranexamic acid (TXA)
Trial: 24650447
Drug: Budesonide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (400 µg) plus Formoterol (12 µg)
Trial: 24650447
Drug: Budesonide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (400 µg) plus Doxofylline (400 mg)
Trial: 24650447
Drug: Budesonide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (400 µg) plus Montelukast (10 mg)
Trial: 24650447
Drug: Budesonide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (400 µg) plus Tiotropium (18 µg)
Trial: 22810981
Drug: Folate supplementation
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate supplementation (1 mg/d)
Trial: 20571496
Drug: Vitamin B(6)
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B(6) supplementation (100 mg/day) plus 5 mg/day folic acid
Trial: 20571496
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (5 mg/day folic acid only)
Trial: 18055960
Drug: Postcard intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postcard intervention (plus treatment as usual)
Trial: 16032446
Drug: High-dose buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose buprenorphine (BH group)
Trial: 16032446
Drug: Low-dose buprenorphine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose buprenorphine (BL group)
Trial: 11878655
Drug: Paracetamol +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol + NSAID
Trial: 10438047
Drug: HbNOMP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HbNOMP vaccine
Trial: 2341658
Drug: Topical interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical interferon alpha 2b gel (30 million IU/gm), applied 4 times a day for 4 weeks
Trial: 2341658
Drug: Placebo preparation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo preparation, applied 4 times a day for 4 weeks
Trial: 6989438
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplements (ergocalciferol, 1000 IU/day)